HealthVirtual Heart Simulations Reach 2,000 Clinical Cases as U.S. FDA Establishes Global Standard for Digital TrialsSalvado•Mar 21, 2026
biotechnologyProtara's Bladder Cancer Drug Faces 70% Failure Risk in Trial Watched Across Global Oncology MarketsViaNews Editorial Team•Feb 26, 2026
Pharmaceutical RegulationFDA Moves to Ban Compounded GLP-1 Drugs, Ending $400-Per-Month Alternative to $1,300 Brand Weight-Loss MedicationsViaNews Editorial Team•Feb 21, 2026
pharmaceuticalsNovakand-SVF Vaccines merger faces €2-4M monthly regulatory burn in multi-jurisdiction approval raceViaNews Editorial Team•Feb 20, 2026
Health & ScienceCellectis Bets on Off-the-Shelf CAR-T Revolution as $700M Peak Sales Forecast Puts Global Cell Therapy Race in FocusViaNews Editorial Team•Feb 18, 2026
AnalysisMajor Drugmakers Reshape Cancer Treatment Through Billion-Dollar Acquisitions, FDA ApprovalsViaNews Editorial Team•Feb 15, 2026
